Isolation and phenotypic characterization of cancer stem-like side population cells in colon cancer

被引:11
作者
Feng, Long [1 ]
Wu, Jian-Bing [1 ]
Yi, Feng-Ming [1 ]
机构
[1] Nanchang Univ, Dept Oncol, Affiliated Hosp 2, Nanchang 330006, Jiangxi, Peoples R China
关键词
cancer stem cells; chemotherapy; side population cells; tumor recurrence; apoptosis; TUMOR-CELLS; INTERLEUKIN-4; IDENTIFICATION; EXPRESSION; RESISTANCE; AUTOCRINE; CAPACITY; SURVIVAL; GROWTH; DEATH;
D O I
10.3892/mmr.2015.3801
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies in cancer biology suggest that chemotherapeutic drug resistance and tumor relapse are driven by cells within a tumor termed 'cancer stem cells'. In the present study, a Hoechst 33342 dye exclusion technique was used to identify cancer stem-like side population (SP) cells in colon carcinoma, which accounted for 3.4% of the total cell population. Following treatment with verapamil, the population of SP cells was reduced to 0.6%. In addition, the sorted SP cells exhibited marked multidrug resistance and enhanced cell survival rates compared with non-SP cells. The SP cells were able to generate more tumor spheres and were CD133 positive. Subsequent biochemical analysis revealed that the levels of the adenosine triphosphate-binding cassette sub-family G member 2 transporter protein, B-cell lymphoma anti-apoptotic factor and autocrine production of interleukin-4 were significantly enhanced in the colon cancer SP cells, which contributed to drug resistance, protection of the cells from apoptosis and tumor recurrence. Therefore, the findings suggested that treatment failure and colon tumorigenesis is dictated by a small population of SP cells, which indicate a potential target in future therapies.
引用
收藏
页码:3531 / 3536
页数:6
相关论文
共 24 条
[1]   Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer [J].
Bapat, SA ;
Mali, AM ;
Koppikar, CB ;
Kurrey, NK .
CANCER RESEARCH, 2005, 65 (08) :3025-3029
[2]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[3]   Prospective identification of tumorigenic prostate cancer stem cells [J].
Collins, AT ;
Berry, PA ;
Hyde, C ;
Stower, MJ ;
Maitland, NJ .
CANCER RESEARCH, 2005, 65 (23) :10946-10951
[4]   IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins [J].
Conticello, C ;
Pedini, F ;
Zeuner, A ;
Patti, M ;
Zerilli, M ;
Stassi, G ;
Messina, A ;
Peschle, C ;
De Maria, R .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5467-5477
[5]   INTERLEUKIN-4 PROTECTS CHRONIC LYMPHOCYTIC LEUKEMIC B-CELLS FROM DEATH BY APOPTOSIS AND UP-REGULATES BCL-2 EXPRESSION [J].
DANCESCU, M ;
RUBIOTRUJILLO, M ;
BIRON, G ;
BRON, D ;
DELESPESSE, G ;
SARFATI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1319-1326
[6]   Tumour stem cells and drug resistance [J].
Dean, M ;
Fojo, T ;
Bates, S .
NATURE REVIEWS CANCER, 2005, 5 (04) :275-284
[7]   In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells [J].
Dontu, G ;
Abdallah, WM ;
Foley, JM ;
Jackson, KW ;
Clarke, MF ;
Kawamura, MJ ;
Wicha, MS .
GENES & DEVELOPMENT, 2003, 17 (10) :1253-1270
[8]   Chemotherapy resistance of glioblastoma stem cells [J].
Eramo, A. ;
Ricci-Vitiani, L. ;
Zeuner, A. ;
Pallini, R. ;
Lotti, F. ;
Sette, G. ;
Pilozzi, E. ;
Larocca, L. M. ;
Peschle, C. ;
De Maria, R. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (07) :1238-1241
[9]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[10]   A distinct "side population" of cells with high drug efflux capacity in human tumor cells [J].
Hirschmann-Jax, C ;
Foster, AE ;
Wulf, GG ;
Nuchtern, JG ;
Jax, TW ;
Gobel, U ;
Goodell, MA ;
Brenner, MK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (39) :14228-14233